T 0851/19 (Tablets comprising Sorafenib Tosylate / BAYER HEALTHCARE LLC) of 17.02.2022

European Case Law Identifier: ECLI:EP:BA:2022:T085119.20220217
Date of decision: 17 February 2022
Case number: T 0851/19
Online on: 10 March 2022
Petition for review of: -
Application number: 06707141.5
IPC class: A61K 9/36 A61K 9/20 A61P 35/00 A61K 31/4412 A61K 9/22
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREA FOR THE TREATMENT OF CANCER
Applicant name: Bayer HealthCare LLC
Opponent name: Altmann, Andreas
Board: 3.3.07
Headnote: -
Relevant legal provisions: European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Keywords: Representation - change of professional representative
Inventive step - (no)
Late-filed auxiliary requests - admitted (no)
Catchword: -
Cited cases: -
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.